Understanding OUR Cytokine-Based Immunotherapy Candidates Our Dedication extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment choices remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Investigate Our Pipeline https://financefeeds.com/defi-presale-to-watch-in-february-2025-priced-at-0-015-with-a-potential-43x-gain/